The Community Guide

- gsearch

Search Results

Narrow Results:

2015 3
2013 1
2012 1

Journal Article 5

1 - 5 of 5 Results

Refine Results

Refine Results:

Validation of Nijmegen-Bethesda Assay Modifications to Allow Inhibitor Measurement during Replacement Therapy and Facilitate Inhibitor Surveillance

CITE Title : Validation of Nijmegen-Bethesda Assay Modifications to Allow Inhibitor Measurement during Replacement Therapy and Facilitate Inhibitor Surveillance Personal Author(s) : Miller, C. H.;Platt, S. J.;Rice, A. S.;Kelly, F.;Soucie, J. M.; Corporate Authors(s) : Hemophilia Inhibitor Research Study Investigators Published Date : 6 2012;6-2012; Source : J Thromb Haemost. 10(6):1055-1061 URL : https://stacks.cdc.gov/view/cdc/33790 Miller, C. H. et al. (2012). Validation of Nijmegen-Bethesda Assay Modifications to Allow Inhibitor Measurement during Replacement Therapy and Facilitate Inhibitor Surveillance. 10(6). Miller, C. H. et al. "Validation of Nijmegen-Bethesda Assay Modifications to Allow Inhibitor Measurement during Replacement Therapy and Facilitate Inhibitor Surveillance" 10, no. 6 (2012) Miller, C. H. et al. "Validation of Nijmegen-Bethesda Assay Modifications to Allow Inhibitor Measurement during Replacement Therapy and Facilitate Inhibitor Surveillance" vol. 10, no. 6, 2012 Export RIS Citation Information.

:

Miller, C. H. ;

Platt, S. J.

6 2012 | J Thromb Haemost. 10(6):1055-1061

:

BackgroundAs part of a pilot U.S. inhibitor surveillance project initiated at the Centers for Disease Control and Prevention (CDC) in 2006, centralize...
Characteristics of hemophilia patients with factor VIII inhibitors detected by prospective screening

CITE Title : Characteristics of hemophilia patients with factor VIII inhibitors detected by prospective screening Personal Author(s) : Miller, Connie H.;Rice, Anne S.;Boylan, Brian;Payne, Amanda B.;Kelly, Fiona M.;Escobar, Miguel A.;Gill, Joan;Leissinger, Cindy;Soucie, J. Michael; Corporate Authors(s) : Hemophilia Inhibitor Research Study Investigators Published Date : 10 2015;10-2015; Source : Am J Hematol. 90(10):871-876 URL : https://stacks.cdc.gov/view/cdc/36468 Miller, Connie H. et al. (2015). Characteristics of hemophilia patients with factor VIII inhibitors detected by prospective screening. 90(10). Miller, Connie H. et al. "Characteristics of hemophilia patients with factor VIII inhibitors detected by prospective screening" 90, no. 10 (2015) Miller, Connie H. et al. "Characteristics of hemophilia patients with factor VIII inhibitors detected by prospective screening" vol. 90, no. 10, 2015 Export RIS Citation Information.

:

Miller, Connie H. ;

Rice, Anne S.

10 2015 | Am J Hematol. 90(10):871-876

:

Characteristics of inhibitors identified by prospective screening may differ from those detected clinically. In a prospective study at 17 hemophilia c...
Comparison of Clot-based, Chromogenic, and Fluorescence Assays for Measurement of Factor VIII Inhibitors in the U.S. Hemophilia Inhibitor Research Study

CITE Title : Comparison of Clot-based, Chromogenic, and Fluorescence Assays for Measurement of Factor VIII Inhibitors in the U.S. Hemophilia Inhibitor Research Study Personal Author(s) : Miller, Connie H.;Rice, Anne S.;Boylan, Brian;Shapiro, Amy D.;Lentz, Steven R.;Wicklund, Brian M.;Kelly, Fiona M.;Soucie, J. Michael; Corporate Authors(s) : Hemophilia Inhibitor Research Study Investigators Published Date : 7 2013;7-2013; Source : J Thromb Haemost. 11(7):1300-1309 URL : https://stacks.cdc.gov/view/cdc/31742 Miller, Connie H. et al. (2013). Comparison of Clot-based, Chromogenic, and Fluorescence Assays for Measurement of Factor VIII Inhibitors in the U.S. Hemophilia Inhibitor Research Study. 11(7). Miller, Connie H. et al. "Comparison of Clot-based, Chromogenic, and Fluorescence Assays for Measurement of Factor VIII Inhibitors in the U.S. Hemophilia Inhibitor Research Study" 11, no. 7 (2013) Miller, Connie H. et al. "Comparison of Clot-based, Chromogenic, and Fluorescence Assays for Measurement of Factor VIII Inhibitors in the U.S. Hemophilia Inhibitor Research Study" vol. 11, no. 7, 2013 Export RIS Citation Information.

:

Miller, Connie H. ;

Rice, Anne S.

7 2013 | J Thromb Haemost. 11(7):1300-1309

:

BackgroundDetection and validation of inhibitors (antibodies) to hemophilia treatment products are important for clinical care, evaluation of product ...
Characterization of the anti-factor VIII immunoglobulin profile in patients with hemophilia A by use of a fluorescence-based immunoassay

CITE Title : Characterization of the anti-factor VIII immunoglobulin profile in patients with hemophilia A by use of a fluorescence-based immunoassay Personal Author(s) : Boylan, Brian;Rice, Anne S.;Dunn, Amy L.;Tarantino, Michael D.;Brettler, Doreen B.;Barrett, John C.;Miller, Connie H.; Corporate Authors(s) : Hemophilia Inhibitor Research Study Investigators Published Date : 1 2015;1-2015; Source : J Thromb Haemost. 13(1):47-53 URL : https://stacks.cdc.gov/view/cdc/30356 Boylan, Brian et al. (2015). Characterization of the anti-factor VIII immunoglobulin profile in patients with hemophilia A by use of a fluorescence-based immunoassay. 13(1). Boylan, Brian et al. "Characterization of the anti-factor VIII immunoglobulin profile in patients with hemophilia A by use of a fluorescence-based immunoassay" 13, no. 1 (2015) Boylan, Brian et al. "Characterization of the anti-factor VIII immunoglobulin profile in patients with hemophilia A by use of a fluorescence-based immunoassay" vol. 13, no. 1, 2015 Export RIS Citation Information.

:

Boylan, Brian ;

Rice, Anne S.

1 2015 | J Thromb Haemost. 13(1):47-53

:

BackgroundThe development of neutralizing antibodies, referred to as inhibitors, against factor VIII (FVIII) is a major complication associated with F...
Evaluation of von Willebrand factor phenotypes and genotypes in Hemophilia A patients with and without identified F8 mutations

CITE Title : Evaluation of von Willebrand factor phenotypes and genotypes in Hemophilia A patients with and without identified F8 mutations Personal Author(s) : Boylan, Brian;Rice, Anne S.;De Staercke, Christine;Eyster, M. Elaine;Yaish, Hassan M.;Knoll, Christine M.;Bean, Christopher J.;Miller, Connie H.; Corporate Authors(s) : Hemophilia Inhibitor Research Study Investigators Published Date : 6 2015;6-2015; Source : J Thromb Haemost. 13(6):1036-1042 URL : https://stacks.cdc.gov/view/cdc/32330 Boylan, Brian et al. (2015). Evaluation of von Willebrand factor phenotypes and genotypes in Hemophilia A patients with and without identified F8 mutations. 13(6). Boylan, Brian et al. "Evaluation of von Willebrand factor phenotypes and genotypes in Hemophilia A patients with and without identified F8 mutations" 13, no. 6 (2015) Boylan, Brian et al. "Evaluation of von Willebrand factor phenotypes and genotypes in Hemophilia A patients with and without identified F8 mutations" vol. 13, no. 6, 2015 Export RIS Citation Information.

:

Boylan, Brian ;

Rice, Anne S.

6 2015 | J Thromb Haemost. 13(6):1036-1042

:

BackgroundHemophilia A (HA) is an X-linked bleeding disorder caused by a deficiency in factor VIII (FVIII). von Willebrand disease (VWD) is characteri...